Literature DB >> 18591292

Is genetic information relevantly different from other kinds of non-genetic information in the life insurance context?

P J Malpas1.   

Abstract

Within the medical, legal and bioethical literature, there has been an increasing concern that the information derived from genetic tests may be used to unfairly discriminate against individuals seeking various kinds of insurance; particularly health and life insurance. Consumer groups, the general public and those with genetic conditions have also expressed these concerns, specifically in the context of life insurance. While it is true that all insurance companies may have an interest in the information obtained from genetic tests, life insurers potentially have a very strong incentive to (want to) use genetic information to rate applicants, as individuals generally purchase their own cover and may want to take out very large policies. This paper critically focuses on genetic information in the context of life insurance. We consider whether genetic information differs in any relevant way from other kinds of non-genetic information required by and disclosed to life insurance companies by potential clients. We will argue that genetic information should not be treated any differently from other types of health information already collected from those wishing to purchase life insurance cover.

Entities:  

Mesh:

Year:  2008        PMID: 18591292     DOI: 10.1136/jme.2007.023101

Source DB:  PubMed          Journal:  J Med Ethics        ISSN: 0306-6800            Impact factor:   2.903


  3 in total

1.  Genetic information, insurance and a pluralistic approach to justice.

Authors:  Jonathan Pugh
Journal:  J Med Ethics       Date:  2021-04-15       Impact factor: 2.903

2.  A protocol for the identification and validation of novel genetic causes of kidney disease.

Authors:  Andrew Mallett; Chirag Patel; Barbara Maier; Julie McGaughran; Michael Gabbett; Minoru Takasato; Anne Cameron; Peter Trnka; Stephen I Alexander; Gopala Rangan; Michel C Tchan; Georgina Caruana; George John; Cathy Quinlan; Hugh J McCarthy; Valentine Hyland; Wendy E Hoy; Ernst Wolvetang; Ryan Taft; Cas Simons; Helen Healy; Melissa Little
Journal:  BMC Nephrol       Date:  2015-09-15       Impact factor: 2.388

3.  Rethinking the ethical principles of genomic medicine services.

Authors:  Stephanie B Johnson; Ingrid Slade; Alberto Giubilini; Mackenzie Graham
Journal:  Eur J Hum Genet       Date:  2019-09-18       Impact factor: 4.246

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.